UA116877C2 - Сполука з антибактеріальною і/абопротивірусною активністю - Google Patents

Сполука з антибактеріальною і/абопротивірусною активністю

Info

Publication number
UA116877C2
UA116877C2 UAA201406790A UAA201406790A UA116877C2 UA 116877 C2 UA116877 C2 UA 116877C2 UA A201406790 A UAA201406790 A UA A201406790A UA A201406790 A UAA201406790 A UA A201406790A UA 116877 C2 UA116877 C2 UA 116877C2
Authority
UA
Ukraine
Prior art keywords
antibacterial
antiviral activity
hemin
novel derivatives
sernh2
Prior art date
Application number
UAA201406790A
Other languages
English (en)
Inventor
Владімір Євгєньєвіч Нєбольсін
Галіна Алєксандровна Желтухіна
Сергій Олександрович Окороченков
Original Assignee
Общєство С Огранічєнной Отвєтствєнностью "Фармінтерпрайсез"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общєство С Огранічєнной Отвєтствєнностью "Фармінтерпрайсез" filed Critical Общєство С Огранічєнной Отвєтствєнностью "Фармінтерпрайсез"
Publication of UA116877C2 publication Critical patent/UA116877C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Винахід стосується сполуки загальної формули (I) , де R1 і R2, обидва, являють собою ArgNH2, GlyNH2, SerNH2, Glu(ArgNH2)ArgNH2, Glu(SerNH2)SerNH2, Glu(GlyNH2)GlyNH2 або ArgSerNH2, SerArgNH2; Men+ являє собою Fe2+ або Fe3+; Наl- являє собою F-, Сl-, Вr- або І,. та фармацевтичної композиції, що має антибактеріальну і/або противірусну активність, яка включає як активний інгредієнт дану сполуку. Винахід також стосується способу одержання сполуки та лікарського засобу, який її містить.
UAA201406790A 2011-11-17 2012-11-15 Сполука з антибактеріальною і/абопротивірусною активністю UA116877C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2011146831/04A RU2475498C1 (ru) 2011-11-17 2011-11-17 Новые производные гемина с антибактериальной и противовирусной активностью
PCT/RU2012/000939 WO2013073998A2 (ru) 2011-11-17 2012-11-15 Новые производные гемина с антибактериальной и противовирусной активностью

Publications (1)

Publication Number Publication Date
UA116877C2 true UA116877C2 (uk) 2018-05-25

Family

ID=48430327

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201406790A UA116877C2 (uk) 2011-11-17 2012-11-15 Сполука з антибактеріальною і/абопротивірусною активністю

Country Status (14)

Country Link
US (1) US9605013B2 (uk)
EP (1) EP2781525B1 (uk)
CN (1) CN104039824B (uk)
CY (1) CY1122496T1 (uk)
DK (1) DK2781525T3 (uk)
EA (1) EA023667B1 (uk)
ES (1) ES2755937T3 (uk)
HU (1) HUE046503T2 (uk)
PL (1) PL2781525T3 (uk)
PT (1) PT2781525T (uk)
RU (1) RU2475498C1 (uk)
SI (1) SI2781525T1 (uk)
UA (1) UA116877C2 (uk)
WO (1) WO2013073998A2 (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2967056B1 (en) 2013-03-15 2018-02-21 Suncor Energy Inc. Herbicidal compositions
RU2656595C1 (ru) * 2018-03-16 2018-06-06 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Циклическое производное гемина с антимикробными свойствами и способ его синтеза
CN111848656B (zh) * 2020-06-24 2023-03-14 天津大学 离子修饰的原卟啉镓化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002242A1 (en) 1990-07-31 1992-02-20 The Rockefeller University Use of metalloporphyrins to potentiate aids therapy
RU2238950C2 (ru) * 2002-04-25 2004-10-27 Небольсин Владимир Евгеньевич Производные гемина и их фармацевтически приемлемые соли, способ получения, применение и фармацевтическая композиция
RU2250906C2 (ru) * 2003-07-10 2005-04-27 Небольсин Владимир Евгеньевич Способы получения геминпептидов и их применение в качестве нуклеолитических агентов
RU2296131C2 (ru) * 2004-11-26 2007-03-27 ООО "Фарминтерпрайсез" Геминпептид, его фармацевтически приемлемые соли и применение в качестве противовирусного и вирулецидного агента
RU2280649C1 (ru) * 2004-11-26 2006-07-27 ООО "Фарминтерпрайсез" Геминпептиды, их фармацевтически приемлемые соли, фармкомпозиция и применение в качестве противоопухолевых агентов
RU2404191C2 (ru) * 2007-07-09 2010-11-20 ООО "Фарминтерпрайсез" Производные гемина или их фармацевтически приемлемые соли, способ получения, композиция и применение
RU2415868C1 (ru) 2009-09-10 2011-04-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Производные гемина, обладающие антимикробной активностью, или их фармацевтически приемлемые соли, способ получения, фармкомпозиция и применение

Also Published As

Publication number Publication date
EP2781525A4 (en) 2015-05-27
EA201490963A1 (ru) 2014-12-30
US9605013B2 (en) 2017-03-28
CY1122496T1 (el) 2021-01-27
CN104039824B (zh) 2017-06-06
EP2781525B1 (en) 2019-10-16
HUE046503T2 (hu) 2020-03-30
RU2475498C1 (ru) 2013-02-20
DK2781525T3 (da) 2019-11-18
PL2781525T3 (pl) 2020-05-18
EP2781525A2 (en) 2014-09-24
PT2781525T (pt) 2019-12-05
EA023667B1 (ru) 2016-06-30
CN104039824A (zh) 2014-09-10
ES2755937T3 (es) 2020-04-24
SI2781525T1 (sl) 2020-02-28
US20150031854A1 (en) 2015-01-29
WO2013073998A2 (ru) 2013-05-23
WO2013073998A3 (ru) 2013-08-08

Similar Documents

Publication Publication Date Title
MY165087A (en) Neprilysin inhibitors
MX342212B (es) Inhibidores de neprilisina.
MD4602B1 (ro) Inhibitori ai virusului hepatic C
MY170935A (en) Neprilysin inhibitors
MX354476B (es) Inhibidores de neprilisina.
MY168201A (en) Agricultural And Horticultural Fungicidal Composition
MA34064B1 (fr) Compose heterocyclique
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
EA201270216A1 (ru) Фармацевтический состав
IN2015DN03998A (uk)
WO2013106761A3 (en) Antimicrobial agents
IN2014CN04449A (uk)
WO2013177534A3 (en) New salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
MY169319A (en) 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
PH12018500378A1 (en) Novel annelated phenoxyacetamides
PH12014502743A1 (en) Carbamate/urea derivatives
UA112556C2 (uk) Інсектицидні похідні 2-метоксибензамідів
MX348979B (es) Agente de control de enfermedades de las plantas.
WO2013106756A3 (en) Antimicrobial agents
UA116877C2 (uk) Сполука з антибактеріальною і/абопротивірусною активністю
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
PH12015500373A1 (en) Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease
MY162537A (en) dihydro-oxazolobenzodiazepinone derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds
SA112330437B1 (ar) تركيبات دوائية محتوية على عامل منوم او مخدر وطريقة تحضيرها
WO2012018662A3 (en) Fused-imidazoyl compounds useful as antimicrobial agents